Only in recent years, attentions have been drawn to the significance of expressing killer cell inhibitory receptors (KIR) in T cells KIRs specifically bind to the corresponding region of the MHC class I molecules and ...Only in recent years, attentions have been drawn to the significance of expressing killer cell inhibitory receptors (KIR) in T cells KIRs specifically bind to the corresponding region of the MHC class I molecules and transmit negative signals to prevent cytotoxity of T cells. When the ligands of KIRs are missing, the lysis of the target cells can’t be avoided. Perhaps the existence of KIRs is the main mechanism for preventing T cells from attacking autologous tissues. The recognition mechanism of the interaction between the KIR + donor T cells and the recipient’s MHC class I molecule expressing tissue cells might shed light on the establishment of the immunotolerance for the prevention of allo-graft rejection and graft-versus-host disease.展开更多
转化医学这一概念最早是在2003年由美国国立卫生研究院（National Institutes of Health）提出,转化医学的核心内容是要将医学生物学基础研究成果迅速有效地转化为可在临床实际应用的理论、技术、方法和药物,它要在实验室到病房（Bench ...转化医学这一概念最早是在2003年由美国国立卫生研究院（National Institutes of Health）提出,转化医学的核心内容是要将医学生物学基础研究成果迅速有效地转化为可在临床实际应用的理论、技术、方法和药物,它要在实验室到病房（Bench To Bedside,简称B2B）之间架起一条快速通道,是双向开放的研究过程[1-2]。展开更多
基金国家自然科学基金资助项目 (No .30 1 70 395)中国博士后科学基金资助项目 (No .2 0 0 1 - 2 9)
文摘Only in recent years, attentions have been drawn to the significance of expressing killer cell inhibitory receptors (KIR) in T cells KIRs specifically bind to the corresponding region of the MHC class I molecules and transmit negative signals to prevent cytotoxity of T cells. When the ligands of KIRs are missing, the lysis of the target cells can’t be avoided. Perhaps the existence of KIRs is the main mechanism for preventing T cells from attacking autologous tissues. The recognition mechanism of the interaction between the KIR + donor T cells and the recipient’s MHC class I molecule expressing tissue cells might shed light on the establishment of the immunotolerance for the prevention of allo-graft rejection and graft-versus-host disease.
文摘转化医学这一概念最早是在2003年由美国国立卫生研究院（National Institutes of Health）提出,转化医学的核心内容是要将医学生物学基础研究成果迅速有效地转化为可在临床实际应用的理论、技术、方法和药物,它要在实验室到病房（Bench To Bedside,简称B2B）之间架起一条快速通道,是双向开放的研究过程[1-2]。
